Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit

Authors

Jose L. Molinuevo, Pasqual Maragall Foundation
Jordi Cami, Universitat Pompeu Fabra
Xavier Carne, Hospital Clinic and IDIBAPS
Maria C. Carrillo, Alzheimer's Association
Jean Georges, Alzheimer Europe
Maria B. Isaac, European Medicines Agency (EMA)
Zaven Khachaturian, The Campaign to Prevent Alzheimer by 2020 (PAD2020)
Scott Y.H. Kim, National Institutes of Health
John C. Morris, Washington University School of Medicine in St. Louis
Florence Pasquier, Universite du Droit et de la Sante (Lille II)
Craig Ritchie, University of Edinburgh
Reisa Sperling, Harvard University
Jason Karlawish, University of Pennsylvania

Journal

Alzheimer's & Dementia

Publication Date

2016

Volume

12

Issue

5

Inclusive Pages

614-622

Document Type

Open Access Publication

DOI

10.1016/j.jalz.2016.01.009

Rights and Permissions

Molinuevo JL, Cami J, Carne X, et al (2017) Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit. Alzheimer's & Dementia, 12(5):614-622. https://doi.org/10.1016/j.jalz.2016.01.009 Copyright 2016 The Authors. Published by Elsevier Inc. on behalf of Alzheimer’s Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Molinuevo, Jose L.; Cami, Jordi; Carne, Xavier; Carrillo, Maria C.; Georges, Jean; Isaac, Maria B.; Khachaturian, Zaven; Kim, Scott Y.H.; Morris, John C.; Pasquier, Florence; Ritchie, Craig; Sperling, Reisa; and Karlawish, Jason, "Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit." Alzheimer's & Dementia. 12, 5. 614-622. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/6311